---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-024454"
form_type: "8-K"
ticker: "WGRX"
cik: "0002030763"
company_name: "Wellgistics Health, Inc."
filed_at: "2026-05-19T21:11:19+00:00"
generated_at: "2026-05-19T21:14:09.050153+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Wellgistics Q1 revenue $0.93M, net loss $7.7M; terminates Neuritek/WellCare LOIs; guides Q2 ~$1.78M

## Summary
- Revenue $0.93M in Q1 2026 vs $0.49M Q4 2025; expects Q2 rev $1.78M (with $0.86M recognized through May 18).
- Net operating loss $7.74M vs $32.43M prior year; EPS -$0.07 vs -$0.62 on 104.6M shares.
- Wellgistics Pharmacy monthly rev grew from ~$0.1M (Nov 2025) to ~$0.6M (Apr 2026).
- Terminated non-binding LOIs with Neuritek and WellCare; advanced discussions with Datavault AI for HaaS expansion.
- Partnership with Tollo Health and NFL Alumni Health; Health Lives Here app launch targeted Aug 2026.

## SEC filing metadata
- accession: 0001493152-26-024454
- form_type: 8-K
- ticker: WGRX
- cik: 0002030763
- company_name: Wellgistics Health, Inc.
- filed_at: 2026-05-19T21:11:19+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030763/000149315226024454/0001493152-26-024454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030763/000149315226024454/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-024454
- JSON: https://secwatch.observer/filing/0001493152-26-024454.json
- Plain text: https://secwatch.observer/filing/0001493152-26-024454.txt

## Key facts
- Earnings Releases
  Wellgistics Health, Inc. reported first quarter ended March 31, 2026 results: revenue $0.929 million, net income net operating loss of $7.742 million, EPS $0.07. Guidance initiated.
  - Period: first quarter ended March 31, 2026
  - Revenue: $0.929 million
  - Net income: net operating loss of $7.742 million
  - EPS: $0.07
  - Guidance: initiated
  - Result: reported results
  source text: revenue opportunities,”noted Mr. Patel. First Quarter 2026 Corporate Highlights ● Sequential quarter over quarter revenue growth: ○ Q4-2025: $0.486 million ○ Q1-2026: $0.929 million ○ Q2-2026: The Company expects revenue of $1.775 million (projected, $0.86M already recognized through May 18, 2026) ● Added quantum key encryption functionality to the
  evidence_url: https://www.sec.gov/Archives/edgar/data/2030763/000149315226024454/0001493152-26-024454-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.